Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Sandpiper Ventures

Founders Cathy Bennett Chere Chapman Danielle Graham Rhiannon Davies

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 21
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 12
Rounds per year 5.25
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.38
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Software
  • Wellness
  • Health Care
  • SaaS
  • Insurance

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Sandpiper Ventures:
Typical Co-investors
Sandpiper Ventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Sandpiper Ventures:
There are no funds here. If we find new data, we will add it here.

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Simmunome AI

Artificial Intelligence
Biotechnology
Genetics
$1M18 Sep 2023 Montreal, Quebec, Canada

QuickFacts

Apps
Insurance
SaaS
$874K08 Jun 2023 Bedford, Nova Scotia, Canada

Swiftsure Innovations

Health Care
Medical Device
Wellness
$1M18 May 2023 Newfoundland, Pennsylvania, United States

QuickFacts

Apps
Insurance
SaaS
23 Feb 2023 Bedford, Nova Scotia, Canada

SiftMed

Analytics
Software
$2M07 Feb 2023 St. John's, Newfoundland, Canada

Shoelace Learning

$4M02 Feb 2023 Halifax, Nova Scotia, Canada

Gotcare

Health Care
Hospital
Wellness
01 Feb 2023 Old Toronto, Ontario, Canada

Shoelace Learning

$3M08 Nov 2022 Halifax, Nova Scotia, Canada

Fable

Consumer Goods
Manufacturing
$6M28 Jul 2022 Vancouver, British Columbia, Canada

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sandpiper Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 21
Average round size 2M
Rounds per year 5.25
Peak activity year 2023
Lead investments 3
Follow on index 0.38
Group Appearance index 0.71

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Simmunome AI

Artificial Intelligence
Biotechnology
Genetics
$1M18 Sep 2023 Montreal, Quebec, Canada

QuickFacts

Apps
Insurance
SaaS
$874K08 Jun 2023 Bedford, Nova Scotia, Canada

Swiftsure Innovations

Health Care
Medical Device
Wellness
$1M18 May 2023 Newfoundland, Pennsylvania, United States

QuickFacts

Apps
Insurance
SaaS
23 Feb 2023 Bedford, Nova Scotia, Canada

SiftMed

Analytics
Software
$2M07 Feb 2023 St. John's, Newfoundland, Canada

Shoelace Learning

$4M02 Feb 2023 Halifax, Nova Scotia, Canada

Gotcare

Health Care
Hospital
Wellness
01 Feb 2023 Old Toronto, Ontario, Canada

Shoelace Learning

$3M08 Nov 2022 Halifax, Nova Scotia, Canada

Fable

Consumer Goods
Manufacturing
$6M28 Jul 2022 Vancouver, British Columbia, Canada
Crunchbase icon

Content report

The following text will be sent to our editors: